Golden, Thanks @dachopper
I just wanted that to be crystal clear for everyone we are talking “annual” 2 Billion in sales for MSB’s first Ryoncil(Rem-L) therapy for Paeds and Adult aGVHD.
And this will be MSB’s smallest therapy use in the larger MSB plan. Full LBP and HF will be many many multiples of this revenue figure if/when Rex is approved.
As I said….Golden.
2024 Here we go again., page-525
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 86854 | 7 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |